These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6469753)

  • 1. Pharmacology and toxicology of sensitizers: mechanism studies.
    Rauth AM
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1293-300. PubMed ID: 6469753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Toxic and radiosensitizing effect of reduced nitroimidazoles on E. coli B/r cells].
    Riabchenko NI; Semin IuA; Petrova KM; Kutmin AI
    Radiobiologiia; 1983; 23(4):505-9. PubMed ID: 6351162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials of radiosensitizers: what should we expect?
    Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):425-9. PubMed ID: 6231272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloronitroimidazoles as radiosensitizers of hypoxic cells in vitro.
    Wideł M; Watras J; Suwiński J; Salwińska E
    Neoplasma; 1987; 34(3):241-51. PubMed ID: 3614460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hypoxic cell radiosensitizers on the activity of ATPases.
    Bara A; Mustea I; Postescu ID
    Int J Radiat Biol Relat Stud Phys Chem Med; 1981 Dec; 40(6):681-4. PubMed ID: 6175593
    [No Abstract]   [Full Text] [Related]  

  • 6. Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
    Astor M; Hall EJ
    Br J Cancer; 1979 May; 39(5):510-5. PubMed ID: 486306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression by hypoxic cell radiosensitizers: a phenomenon of potential clinical importance.
    Rockwell S; Kapp DS
    Int J Radiat Oncol Biol Phys; 1982 Jun; 8(6):1071-3. PubMed ID: 7050051
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole.
    Brown DM; Yu NY; Brown JM; Lee WW
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):435-8. PubMed ID: 7107364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronidazole (flagyl) and misonidazole (Ro-07-0582): reduction by facultative anaerobes and cytotoxic action on hypoxic bacteria and mammalian cells in vivo.
    Basag SH; Dunlop JR; Searle AJ; Willson RL
    Br J Cancer Suppl; 1978 Jun; 3():132-5. PubMed ID: 354677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing of hypoxic cell radiosensitizers in vivo.
    Rauth AM; Chin J; Marchow L; Paciga J
    Br J Cancer Suppl; 1978 Jun; 3():202-5. PubMed ID: 277228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing of hypoxic cell radiosensitizers in vivo.
    Denekamp J
    Cancer Clin Trials; 1980; 3(2):139-48. PubMed ID: 7428137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro assessment of the oncogenic potential of nitroimidazole radiosensitizers.
    Hei TK; Geard CR; Osmak RS; Hall EJ
    Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1653-8. PubMed ID: 3839777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A biochemical neurotoxicity study relating the neurotoxic potential of metronidazole and nitrofurantoin with misonidazole.
    Rose GP; Dewar AJ; Stratford IJ
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):781-5. PubMed ID: 7107414
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioreductive therapies: an overview of drugs and their mechanisms of action.
    Rauth AM; Melo T; Misra V
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):755-62. PubMed ID: 9845091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxic cell radiosensitizers: comparative tests of some electron affinic compounds using epidermal cell survival in vivo.
    Denekamp J; Michael BD; Harris SR
    Radiat Res; 1974 Oct; 60(1):119-32. PubMed ID: 10881705
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles.
    Lindmark DG; Müller M
    Antimicrob Agents Chemother; 1976 Sep; 10(3):476-82. PubMed ID: 791102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic potentiation of the radiosensitization of hypoxic bacterial cells afforded by nitroaromatic compounds.
    Anderson RF; Patel KB
    Radiat Res; 1983 Mar; 93(3):516-24. PubMed ID: 6344127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies of hypoxic-cell radiosensitization using artificially hypoxic skin in vivo.
    Denekamp J; Michael BD; Minchinton AI; Smithen CE; Stewart FA; Stratford MR; Terry NH
    Br J Cancer; 1982 Feb; 45(2):247-55. PubMed ID: 7059473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic transforming potential of nitroimidazole radiosensitizers.
    Hall EJ; Hei TK
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1231-4. PubMed ID: 2523882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers.
    Adams GE; Flockhart IR; Smithen CE; Stratford IJ; Wardman P; Watts ME
    Radiat Res; 1976 Jul; 67(1):9-20. PubMed ID: 940937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.